RE:FDADumbeldorfwhite wrote: Why would the FDA grant breakthrough for 25 patients, of which, didn't even get the right dose? My guess is that is the hold up
To date, the optimized patient cohort is up to 32 evaluated patients. It always amazes me the amount of people whod rather waste time posting uninformed opinions instead of actually spending that time reading the companys MD&A and financial filings to actually educate themselves on their investment.